Old Web
English
Sign In
Acemap
>
Paper
>
DDIS-13. UNDERSTANDING GLIOBLASTOMA SUSCEPTIBILITY TO TOP2-TARGETING DRUGS FOR PERSONALIZED THERAPY
DDIS-13. UNDERSTANDING GLIOBLASTOMA SUSCEPTIBILITY TO TOP2-TARGETING DRUGS FOR PERSONALIZED THERAPY
2018
Chidiebere U. Awah
Edgar Gonzalez-Buendia
Junfei Zhao
Eric Feldstein
Li Chen
Aayushi Mahajan
Louisa Warnke
Lu Wang
Cheol Park
Jan Winter
Silvana Konermann
Ali Shilatifard
C. David James
Raul Rabadan
Patrick Hsu
Mukesh Bansal
Atique U. Ahmed
Adam M. Sonabend
Keywords:
Glioblastoma
Immunology
Cancer research
Medicine
Oncology
personalized therapy
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]